Harvard University at PMWC 2027

Jan 27–29, 2027 Santa Clara, CA ~3k attendees Website

Harvard University takes part in 10 sessions at PMWC 2027 in Santa Clara. Its program centers on early cancer detection and liquid biopsy sensitivity, and it chairs a day on genomic diagnosis and the human phenome. Other sessions cover newborn genomic screening, cell therapy in solid tumors and rare cancers.

OrganizationPMWC 2027 Attendance
Harvard University
Cambridge, MA
Universities & research institutes
Private research university; most of its speakers here are Harvard Medical School faculty in genetics, oncology and pediatrics.
PMWC Pioneer Award honoree
Track
Wed Jan 27
All day
Track 4: From Genomic Diagnosis to the Human Phenome
Track chair
Panel
Wed Jan 27
11:00am
Part of Track 2: Multimodal AI in Diagnostics
AI-Enabled Companion Diagnostics: From Biomarker Discovery to Patient Selection
with intoDNA, Genialis, Illumina +1 more
Panel
Wed Jan 27
11:00am
Part of Track 4: From Genomic Diagnosis to the Human Phenome
Population Genomic Screening: From Newborns to Implementation
with RTI International, UCSF, University of Minnesota +1 more
Panel
Wed Jan 27
1:00pm
Part of Track 3: From Screening to Interception: Diagnostics Enter the Clinic
Treating Disease at the Earliest Stage
with Dana-Farber Cancer Institute, Stanford University
Panel
Wed Jan 27
2:00pm
Part of Track 1: Engineered Cell and Gene Therapy Platforms
Why Cell Therapies Fail in Solid Tumors and What Actually Works
with Stanford University, Rutgers Cancer Institute, USC +1 more
Panel
Wed Jan 27
3:30pm
Part of Track 3: From Screening to Interception: Diagnostics Enter the Clinic
SESSION 5A - Increasing the Signal: Can We Make Liquid Biopsy More Sensitive?
with Johns Hopkins University, Northwestern University, University of Toronto +2 more
Panel
Wed Jan 27
4:15pm
Part of Track 3: From Screening to Interception: Diagnostics Enter the Clinic
SESSION 5B - AI Across Multimodal Signals
with Stanford University, Dana-Farber Cancer Institute, UCSF +1 more
Panel
Thu Jan 28
9:45am
Part of Track 5: Precision Immunology: Autoimmune & Inflammatory Disease
Immune Reset in Autoimmune Disease: CAR-T, in vivo CAR, and Drug-Free Remission
with Bristol Myers Squibb, RA Capital, UCSF +1 more
Panel
Thu Jan 28
3:30pm
Part of Track 3: Liquid Biopsy – Therapy Guidance & Monitoring
MRD as a Surrogate Endpoint for Accelerated Drug Approval: Successes and Challenges
with University of Miami, Virginia Tech, Amgen +4 more
Panel
Thu Jan 28
3:45pm
Part of Track 1: Immunotherapies & Targeted Therapies
Rare Cancers, Basket Trials, and Histology-Agnostic to N-of-1 Playbooks
with Sarah Cannon Research Institute, Friends of Cancer Research, Cancer Commons +1 more
Also
Presenting at the meeting, beyond the sessions above

Explore the full PMWC 2027 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Santa Clara. Leave your work email and we’ll be in touch.

Privacy

Download the full PMWC 2027 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Harvard University

Tell us what you sell and we’ll find the people at Harvard University most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by PMWC or its organizers. Submit a correction